<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-487
Date of Submission: 2024-10-30

This report was submitted by a Patient from Gonzalez, Kerr and Miller Medical Center concerning patient ANON-PX-5039. The subject is a 53-year-old female with a significant medical history including atrial fibrillation, anxiety, chronic kidney disease. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Warfarin (Anticoagulant) administered via the Oral route at a dosage of 300mg, initiated on 2024-09-28 for Thromboembolism prevention and discontinued on 2024-10-29.

On approximately 2024-10-28, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Anaphylaxis, Vomiting. The Anaphylaxis was classified as Mild in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Unknown'. The Vomiting was classified as Severe in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Explain agreement dinner media Mr control building show. Site low laugh national popular myself foot. Whether pay but create pretty see.</data>
report_id: ADR-2024-487
report_date: '2024-10-30'
patient_details:
  patient_id: ANON-PX-5039
  gender: Female
  relevant_history:
  - atrial fibrillation
  - anxiety
  - chronic kidney disease
  age_at_reaction: 53
suspected_drugs:
- drug_name: Warfarin
  dosage: 300mg
  route_of_administration: Oral
  start_date: '2024-09-28'
  indication_for_use: Thromboembolism prevention
  drug_class: Anticoagulant
  end_date: '2024-10-29'
adverse_reactions:
- symptom_name: Anaphylaxis
  onset_date: '2024-10-28'
  severity: Mild
  outcome: Unknown
  intervention_required: true
- symptom_name: Vomiting
  onset_date: '2024-10-28'
  severity: Severe
  outcome: Recovered
  intervention_required: true
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Negative dechallenge
reporting_facility: Gonzalez, Kerr and Miller Medical Center
reporter_type: Patient
notes: Explain agreement dinner media Mr control building show. Site low laugh national
  popular myself foot. Whether pay but create pretty see.
